VIRGINIA BEACH, Va. (PRWEB)
March 10, 2020

Thriveworks, the nation’s leading counseling chain with 100+ offices across the US, opens its second location in Virginia Beach, VA in the Great Neck area.

Thriveworks stands out from other counseling and therapy practices by offering appointments within 24 hours, as well as evening and weekend availability. Additionally, they accept most major insurance plans.

“Many people struggle to find providers who have availability during times that most working people are available, like in the evenings and on the weekends. Thriveworks is the solution to this problem,” says Heidi Faust, Chief Compliance Officer at Thriveworks.

Thriveworks Virginia Beach offers flexible scheduling throughout the week and on weekends. Normal hours of operation are 7:30am-9:00pm, Monday-Friday and 8am-5pm, Saturday-Sunday.

About Thriveworks:

Thriveworks is known for premium mental health care and exceptional customer service. In addition to providing quick, flexible scheduling options, Thriveworks works with most major insurance companies and offers other premium counseling benefits.

Thriveworks provides its clients with a wide range of mental health services, including individual therapy, couples therapy, marriage counseling, family therapy, life coaching, child therapy, and help for specific challenges like depression and anxiety.

The philosophy at Thriveworks is that everyone can benefit from working with a skilled, caring mental health counselor or coach. For more information, call (757) 347-3155 or visit https://thriveworks.com/virginia-beach-therapy/

Share article on social media or email:

Presence Family Care Pack, by People Power

“There’s a tremendous need to dramatically lower the cost of home care while helping seniors live in their homes longer. This project has already produced significant advancements in how senior and family care services can be delivered with today’s best technology and research”, said Gene Wang, CEO

PALO ALTO, Calif. (PRWEB)
March 09, 2020

People Power, a leading healthtech software company providing AI-powered services for senior care, announces today the availability of a caregiving system – Presence Caregiver – designed to address the everyday challenges of providing care for people with Alzheimer’s and other dementias. The free program is offered to caregivers living with a person who has received a diagnosis of dementia or mild cognitive impairment. Participating caregivers must be literate in English, have a smartphone and wireless internet connectivity in the home, and be willing to participate in intermittent study activities. Participants will receive the Presence Caregiver Research Pack and mobile app at no cost, a free Amazon Echo upon installation of the system, and each caregiver will earn at least $150 for completing quick-and-easy questionnaires.

Key findings from the collaborative study will reveal how an intelligent connected solution can be designed to assist in the effort of delivering better care for people with dementia while addressing all-too-common feelings of isolation, stress and loneliness of caregivers. The program is led by People Power and University California Berkeley’s Psychophysiology Laboratory, headed by Dr. Robert W. Levenson.

Visit https://research.presencefamily.com to answer 4 simple questions to see if you qualify to participate in this program.

“The next generation of truly intelligent home care systems must significantly improve the lives of caregivers and patients alike”, said Gene Wang, CEO and cofounder of People Power Co. “There’s a tremendous need to dramatically lower the cost of home care while helping seniors live in their homes longer. This project has already produced significant advancements in how senior and family care services can be delivered with today’s best technology and research.”

The Presence Caregiver Research Pack includes a variety of sensors that are installed in the home, similar to a security system, but without cameras. The sensors gather continuous pattern motion data and, using Artificial Intelligence (AI), create a safety net for the home that alerts caregivers to potential hazards. Data from sensors fuel a menu of helpful services that perform continuous monitoring of occupants. The easy-to-use mobile app connects to and integrates with the wirelessly connected sensors to help understand the real-time and historic activities in the home, distributes alerts, connects with a Trusted Circle of family and friends, and more.

The Presence Caregiver Research Pack provides a variety of helpful caregiving services:

Receive mobile alerts if something appears to be wrong

• Know if someone wandered away from home
• Know if they have likely experienced a fall

Track the current activities of occupants

• Know if and when the front door opened
• Know when medication was accessed

Better understand rest and sleep patterns

• Know what time they went to bed and got up
• Track sleep history and quality for improved health insights

Enable support from family and friends

• Create and delegate helpful tasks to others
• Coordinate family and friends to stay in contact

Improve safety at home

• Call for help with the wirelessly connected button
• Know immediately of a water leak or clogged toilet

Enjoy voice control services with Amazon Echo

• Easily request helpful reminders to take medications
• Make phone calls, check weather, and play music

Join and participate in a caregiving community

• Connect with and receive online advice from caregivers
• Get invited to in-person meetings with fellow caregivers

The program is supported by the National Institutes of Health’s National Institute on Aging through a Small Business Innovation Research grant, #R44 AG059458-01

About People Power

An IoT software company specializing in the development of consumer services for senior care, energy management and home security, People Power leads the industry with advanced AI-powered connected home solutions delivered through brands seeking recurring revenue business growth. For more information visit peoplepowerco.com

Share article on social media or email:

WHITE RIVER JUNCTION, Vt. (PRWEB)
March 09, 2020

The Quinism Foundation and Veterans for Common Sense are calling on Congress to fund critical research into the chronic adverse neurological and psychiatric effects of mefloquine and related quinoline antimalarial drugs, following release of a report by an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine (NASEM). The NASEM committee was charged by the U.S. Department of Veterans Affairs with looking at “long-term health effects” of antimalarial medication, with “special attention” “to possible long-term neurologic effects,” and “long-term psychiatric effects.” [1]

On February 25, 2020, the NASEM committee publicly released its final report. It observed a “disconnect between the level of concern raised–millions of people have used the drugs, and there are many known concurrent events and case reports of adverse events–and the systematic research that has been conducted, particularly in areas such as the use of mefloquine and persistent neurological or psychiatric outcomes.” The committee found “there is a sharp contrast between the abundant amount of literature pertaining to concurrent adverse events that are experienced while a drug is being used or shortly following its cessation and the dearth of information, especially high-quality information, pertaining to adverse experiences after the use of that drug has ended.” [1]

“To address the critical research needs identified by NASEM, Congress should establish chronic quinoline encephalopathy (neuropsychiatric quinism) as a perennial research topic under the Peer-Reviewed Medical Research Program (PRMRP) within the Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP),” said Remington Nevin, MD, MPH, DrPH, executive director of The Quinism Foundation.

The Quinism Foundation and Veterans for Common Sense identified five focus areas for future research, including conducting high-quality epidemiological studies related to persistent health effects of antimalarial quinolines, particularly mefloquine.

“In a chapter titled ‘Improving the Quality of Research on the Long-Term Health Effects of Antimalarial Drugs,'” Dr. Nevin said, “the committee noted the importance of epidemiological study designs that ‘allow for the discovery of symptoms or diagnoses that covary. For example, if certain symptoms or diagnoses occur together in the same patients, there may be reason to consider a syndrome of “neuropsychiatric” symptoms that co-occur, rather than looking individually at separate neurologic or psychiatric experiences.’ The committee also noted that a ‘challenge when studying adverse events of drugs is that the occurrence of adverse events [e.g. prodromal psychiatric symptoms such as nightmares, insomnia, anxiety, depression, restlessness, and confusion during use of mefloquine (i.e., symptomatic exposure)] may cause an individual to decide to modify the dose, or even stop the drug completely, without consulting a health professional.'”

“This focus area should aim to fund epidemiological studies meeting the NASEM Committee’s criteria relative to persistent health effects of antimalarial quinolines, particularly mefloquine – to include valid assessment of symptomatic quinoline exposure and particularly symptomatic mefloquine exposure, and subsequent covarying symptoms or diagnoses consistent with the described presentation of chronic quinoline encephalopathy,” Dr. Nevin said.

Other focus areas identified include defining persistent central nervous system effects of antimalarial quinoline neurotoxicity, defining adverse neurophysiological effects of antimalarial quinolines, disentangling comorbid neuropsychiatric diagnoses confounded by antimalarial quinoline toxicity, and developing effective treatments.

Dr. Nevin said that, “this latter focus area should aim to develop treatable targets and treatments for patients with putative chronic quinoline encephalopathy – including those diagnosed with PTSD or TBI – to improve their health and lives.” Dr. Nevin said in this respect that, “although the committee wrote in its report that it held open sessions during their study to ‘listen to individual veterans and others, such as spouses and advocates, who are concerned about aspects of health that may be related to use of these antimalarial drugs’, the committee was prohibited from reviewing patient reports.”

“Had the committee been directed or allowed to review the medical records of affected patients, the unmet clinical needs of these individuals would have likely been readily apparent,” said Anthony Hardie, National Chair and Director of Veterans for Common Sense, a national veterans organization.

About The Quinism Foundation

The Quinism Foundation, founded in January 2018, in White River Junction, Vermont, promotes and supports education and research on quinism, the family of medical disorders caused by exposure to quinoline drugs, including mefloquine and tafenoquine. Dr. Remington Nevin, Executive Director of The Quinism Foundation, is a board-certified occupational medicine and preventive medicine physician and former U.S. Army medical officer and epidemiologist. He is author of more than 30 scientific publications on malaria and the quinoline antimalarials.

1. National Academies of Sciences, Engineering, and Medicine 2020. Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis. Washington, DC: The National Academies Press. Available at: https://doi.org/10.17226/25688.

Share article on social media or email:

SILVER SPRING, Md. (PRWEB)
March 04, 2020

The Global Recovery Initiatives Foundation (GRI) announced today the addition of four new members to its board of directors: international rock icon Nikki Sixx; entertainment industry legend Allen Kovac; Fors Marsh Group’s (FMG) Director of Special Initiatives Matt Escoubas, and iHeartMedia Vice President Alexandra Cameron.

Pam Cytron, CEO of Pando Systems and board chairman of the GRI said, “We are thrilled to add these new board members who will bring their wisdom, expertise, and networks to expand philanthropy for people in early recovery from substance use disorder (SUD)—a nationwide problem that affects every sector of American life—from individuals and their families to the country’s employers and communities.”

About the New Board Members:

Nikki Sixx is a founding member and the bassist of the band Mötley Crüe (over 100 million albums sold worldwide) as well as the author of three New York Times bestselling books, including his memoir The Heroin Diaries, which will debut as a musical in 2020. He is 18 years sober and has been a dedicated recovery advocate, philanthropist, and public speaker. He is a frequent media contributor to CNN, Fast Company, MSNBC, The Washington Post, The Guardian, and Rolling Stone. He has also spoken to members of Congress for National Alcohol and Drug Addiction Recovery Month.

Allen Kovac, a 40-year veteran of the entertainment industry, founded Better Noise Music (AKA, Eleven Seven Music Group), Tenth Street Entertainment, and TDA Productions. He has developed and promoted a wide range of artists, including Tom Petty, Talking Heads, Willie Nelson, Waylon Jennings, Duran Duran, The Cranberries, Mötley Crüe, and Meatloaf.

In 2006, Allen founded Better Noise Music to give artists an integrated worldwide marketing platform and direct distribution with iTunes, Amazon, Apple Music, Spotify, YouTube, and Deezer. Better Noise has been named the #1 Active Rock label by Mediabase two years in a row (2018 and 2019).

In 2019, Allen was honored by Sir Richard Branson with the Innovator Award at the Association of Independent Music (AIM) Awards.

Allen has produced a number of programs that focus on SUD. He co-produced the highly successful Netflix biopic, The Dirt, based on the best-selling autobiography of the band Mötley Crüe. He also produced Sno Babies, a gripping story about a 16-year-old heroin-addicted honor student that shows how one can begin recovery; the movie is scheduled for release in 2020. In addition, he is the producer of The Heroin Diaries, a theater show based on the bestselling memoir of the same name by Nikki Sixx, which will run in 20 cities across the United States beginning in fall 2020.

Matt Escoubas is Director of Special Initiatives at Fors Marsh Group (FMG) where he oversees the company’s social purpose division tasked with addressing social challenges through in-kind, employee-led project teams. Throughout Matt’s career he has championed causes that strive to improve lives through evidence-based research. He brings more than 25 years of experience to his current role having led a wide array of public health and social change campaigns on behalf of federal and private sector clients. His work spans a range of topics, including opioid use disorder, addiction recovery, heart disease and stroke prevention, tobacco prevention, and pediatric palliative care. His efforts have received multiple industry awards, including a PR News Platinum Award, Bronze Anvil Award, two National Health Information Awards, and three Thoth Awards.

Alexandra Cameron is the Vice President of Strategic Partnerships & Government Initiatives for iHeart Media. She is also a co-founder of the National Opioid Action Coalition (NOAC), which has produced two events and multiple radio campaigns to break the stigma around SUD and has adopted GRI as its charity partner for SUD issues. Before joining iHeart Media, Alexandra led Keek, Inc., a startup social video platform that was one of the first video platforms for Facebook Messenger. At Keek, she was responsible for all business operations, sales, and marketing, and grew the number of registered users to 75 million.

About Better Noise Music

BETTER NOISE MUSIC is the premiere independent music label under BETTER NOISE ENTERTAINMENT, a content creation and marketing company that produces music, books, films, documentaries, TV shows, theatrical productions and tours. Better Noise Music (formerly Eleven Seven Music), founded in 2006 by music industry veteran and independent pioneer Allen Kovac, focuses on artist development and has grown into a music industry independent powerhouse, with a roster including Five Finger Death Punch, AWOLNATION, Mötley Crüe, Atlas Genius, Papa Roach, Bad Wolves, Nothing More and The Hu. Partnering with FUGA, AMPED and Membran, the company operates a global marketing and distribution platform with offices in New York, Los Angeles, Nashville, London, Berlin, Toronto and Sydney. https://betternoise.com/

About FMG

Fors Marsh Group (FMG) applies science and strategy to create positive behavior change in people and program and policy improvements in large organizations and government. This work is conducted within seven core U.S. markets: health, defense, technology, finance, homeland security, policy, and consumer. As a certified B Corporation, FMG’s business practices create positive impact beyond our client portfolio, extending into the community through pro bono service to nonprofits aligned with FMG’s corporate values.

About GRI

The Global Recovery Initiatives Foundation (GRI) is the first and only national community foundation dedicated to building philanthropy for organizations that deliver recovery support services to people with SUD.

GRI funds the expansion of organizations that have demonstrated success in:

• 
  Deploying public, private, and pop culture resources to strengthen the field of recovery;
• Engaging philanthropy leaders to invest in nonprofit, recovery-focused programs and making grants in local communities throughout the United States; and
• Reducing the stigma around SUD and recovery.

For more information, visit: https://globalrecoveryinitiatives.org/